EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hausdorf, G.
Right arrow Articles by Lange, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausdorf, G.
Right arrow Articles by Lange, P. E.

European Journal of Cardio-Thoracic Surgery, Vol 6, 311-317, Copyright © 1992 by European Association for Cardio-thoracic Surgery


ARTICLES

Enoximone in newborns with refractory postoperative low-output states (LOS)

G Hausdorf, N Friedel, F Berdjis, HA Dieterich, JJ Fell, HT Dressler, A Werneyer, R Hetzer and PE Lange
German Heart Center, Berlin.

Enoximone was administered to 16 newborns with postoperative, catecholamine-refractory cardiac low-output states in addition to high- dose catecholamine treatment. Haemodynamic changes were assessed at baseline and during treatment. Haemodynamic parameters were improved in 12 newborns ("responders"), 9 of these survived. Three responders died; one from cardiac low-output and 2 from uncorrectable congenital heart disease verified by autopsy. Four newborns did not respond to enoximone therapy ("non-responders") and died. The haemodynamic effects of enoximone were characterized by an increase in cardiac index (+160%, P less than 0.0008), and a fall in right (-26%, P less than 0.0004) and left (-34%, P less than 0.003) atrial pressures. It is concluded that enoximone can be an effective agent in the treatment of cardiac low- output states refractory to high-dose catecholamines in neonates up to 7 months old.


This article has been cited by other articles:


Home page
NeoReviewsHome page
O. Linderkamp, J. Poschl, and P. Ruef
Blood Cell Deformation in Neonates Who Have Sepsis
NeoReviews, October 1, 2006; 7(10): e517 - e523.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. M Hall and M. P W. Platt
Neonatal flecainide toxicity following supraventricular tachycardia treatment
Ann. Pharmacother., September 1, 2003; 37(9): 1343 - 1344.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.